Ligand Pharmaceuticals stock slides as FDA pushes back Travere’s Filspari decision to April 13

Ligand Pharmaceuticals stock slides as FDA pushes back Travere’s Filspari decision to April 13

Ligand Pharmaceuticals shares fell 10.6% after the FDA extended its review of partner Travere’s Filspari label expansion, resetting the decision deadline to April 13. Travere shares dropped 19%. The FDA classified the latest filing as a “major amendment” but did not request new safety or manufacturing data. The broader biotech sector was little changed.
Coca-Cola stock edges up after KO sets Feb. 10 earnings date; CAGNY appearance next

Coca-Cola stock edges up after KO sets Feb. 10 earnings date; CAGNY appearance next

Coca-Cola shares rose 0.5% to $70.83 Tuesday after the company set Feb. 10 for its Q4 and full-year earnings release and investor call. CEO-elect Henrique Braun and CFO John Murphy will speak at the CAGNY conference in Orlando on Feb. 17. Coke expects a $1 billion impairment charge in Q4 tied to its Africa bottling sale. PepsiCo shares gained 1.4% while the S&P 500 ETF slipped 0.4%.
American Airlines stock drops 3.5% as Delta outlook and credit-card rate-cap worries hit airline shares

American Airlines stock drops 3.5% as Delta outlook and credit-card rate-cap worries hit airline shares

American Airlines shares fell 3.5% to $15.44 Tuesday, underperforming other major U.S. carriers as investors reacted to Delta’s profit forecast and concerns over a proposed 10% cap on credit-card interest rates. The cap could threaten airline loyalty program profits. American will report earnings Jan. 27, the same day the NTSB holds a hearing on a 2025 fatal crash involving one of its regional jets.
Travere Therapeutics stock slides as FDA pushes Filspari FSGS decision into April

Travere Therapeutics stock slides as FDA pushes Filspari FSGS decision into April

Travere Therapeutics shares fell 19% Tuesday after the FDA extended its review of Filspari for broader use in kidney disease, pushing the decision deadline to April 13. The stock hit an intraday low of $22.35 before recovering. Travere forecast $127 million in Q4 U.S. net product sales and ended 2025 with $323 million in cash and equivalents. Analyst Joseph Schwartz warned a formal rejection from the FDA remains possible.
Amphenol stock rises as Barclays, Citi and Truist lift targets after CommScope deal closes

Amphenol stock rises as Barclays, Citi and Truist lift targets after CommScope deal closes

Amphenol shares rose 2.2% to $148.28 Tuesday, bucking a broader market decline after finalizing its $10.5 billion acquisition of CommScope’s CCS business. Analysts at Barclays, Citi, and Truist raised price targets, citing expected sales growth and stronger demand. The company projects CCS will add $4.1 billion in 2026 sales and $0.15 to EPS, excluding costs. Quarterly earnings are due Jan. 28.
Wells Fargo stock slides ahead of earnings as credit-card rate cap talk rattles banks

Wells Fargo stock slides ahead of earnings as credit-card rate cap talk rattles banks

Wells Fargo shares fell 1.6% to $93.44 Tuesday, ahead of its fourth-quarter earnings release set for 7 a.m. ET Wednesday. The drop followed President Trump’s proposal for a 10% cap on credit card interest rates, which hit bank stocks. Trading volume reached 11.4 million shares. Investors are watching credit costs and margins amid policy uncertainty and fresh inflation data.
Western Digital stock ticks up as WDC sets Jan. 29 earnings, putting AI storage demand in focus

Western Digital stock ticks up as WDC sets Jan. 29 earnings, putting AI storage demand in focus

Western Digital shares rose 1.6% to $215.57 on Tuesday, ahead of its fiscal Q2 results set for Jan. 29 after the market closes. The stock has swung sharply in recent sessions, fueled by AI-driven demand for storage and recent bullish comments from Nvidia’s CEO. Analysts expect quarterly EPS of $1.92 and revenue near $2.91 billion. Seagate also gained, while Micron fell 2.3%.
Chevron stock climbs as oil jumps, but drones and a Jan. 17 deadline keep CVX traders on edge

Chevron stock climbs as oil jumps, but drones and a Jan. 17 deadline keep CVX traders on edge

Chevron shares rose 2.2% to $165.95 Tuesday after drones struck two Black Sea tankers, including one chartered by the company. Crude prices jumped as unrest in Iran fueled supply fears, with Brent up 2.5% to $65.44 a barrel. Chevron confirmed all crew are safe. War-risk insurance premiums for Black Sea shipping nearly doubled following the attacks.
Cheniere Energy stock edges up after CEO sets 2026 LNG target — what traders watch next

Cheniere Energy stock edges up after CEO sets 2026 LNG target — what traders watch next

Cheniere Energy shares rose 0.3% to $194.05 after CEO Jack Fusco set a 2026 target to process 10 billion cubic feet of natural gas per day. U.S. LNG export feedgas flows hit a record 19.4 bcfd in January, according to LSEG. The U.S. EIA projects record power demand in 2026, but natural gas’s share of generation is expected to fall as renewables expand. Investors await Cheniere’s next earnings report.
13 January 2026
Plexus stock jumps 7% in midday trade as contract manufacturers rally after CPI

Plexus stock jumps 7% in midday trade as contract manufacturers rally after CPI

Plexus Corp (PLXS) shares surged about 7% to $171.65 Tuesday, outpacing peers in a broad electronics manufacturing rally. The move followed a December inflation report showing consumer prices up 2.7% year-on-year. Analysts expect Plexus to report Q1 EPS near $1.77 on January 28. The stock now trades above the average analyst target of $159.
Bitcoin price today nears $93,500 as Senate crypto bill lifts Coinbase, Strategy stock

Bitcoin price today nears $93,500 as Senate crypto bill lifts Coinbase, Strategy stock

Bitcoin rose 2.2% to $93,478 Tuesday, with Coinbase up 3% and Strategy gaining 4.2% after disclosing a $1.25 billion bitcoin purchase. U.S.-listed spot bitcoin ETFs advanced about 2.3%. Senators late Monday released draft legislation to clarify crypto rules, granting the CFTC more oversight. December CPI rose 0.3%, keeping annual inflation at 2.7% ahead of the Jan. 27-28 Fed meeting.
Lockheed Martin stock nears a fresh high after Jefferies target hike as earnings loom

Lockheed Martin stock nears a fresh high after Jefferies target hike as earnings loom

Lockheed Martin shares rose about 1% Tuesday, peaking at $564. Jefferies raised its price target to $540 but kept a Hold rating, citing possible weakness in 2026 guidance. Lockheed delivered its 350th MH-60R helicopter to the U.S. Navy and hosted Secretary of War Pete Hegseth at its F-35 plant. Investors await fourth-quarter results on Jan. 29 for details on 2026 margins and production.

Stock Market Today

Eli Lilly stock pops as FDA targets cheap weight-loss copycats — what to know before Monday

Eli Lilly stock pops as FDA targets cheap weight-loss copycats — what to know before Monday

7 February 2026
Eli Lilly shares rose 3.7% to $1,058.18 Friday after the FDA said it would act against telehealth firm Hims & Hers for marketing a $49 compounded weight-loss pill. The move followed a sharp selloff Thursday when Hims announced plans to sell a version of Novo Nordisk’s Wegovy. Investors remain uncertain how aggressively regulators will police copycat drugs and pricing in the obesity drug market.
Saudi Aramco share price set for Sunday test after Tadawul ends market-making deal

Saudi Aramco share price set for Sunday test after Tadawul ends market-making deal

7 February 2026
Saudi Exchange approved Merrill Lynch KSA’s exit as market maker for Saudi Aramco, effective Feb. 8. Aramco shares closed at 25.60 riyals Thursday, down 0.06, with 22.1 million traded. The Tadawul index fell 1.3% as Brent crude dropped to $67.93. Aramco set March official selling prices at $2.10 above Argus for North America and $0.65 above ICE Brent for Western Europe.
Meta stock ends week down about 6% as Wall Street fixates on $135 billion AI capex

Meta stock ends week down about 6% as Wall Street fixates on $135 billion AI capex

7 February 2026
Meta closed down 1.3% Friday at $661.46, capping a 6.4% weekly drop as investors questioned heavy AI spending. Amazon and Alphabet also fell after outlining major capital outlays. Meta’s Instagram suffered a brief outage this week. Legal risks persist, with trials involving Meta set for next week in Los Angeles and New Mexico.
Go toTop